Hai Solutions
HAI Solutions is dedicated to protecting every patient by developing innovative vascular access devices that revolutionize intravenous medication delivery and enhance patient safety. They focus on advancing clinical care by addressing challenges related to Intravenous Care and Vascular Access, targeting issues like contamination and infection in healthcare settings. Their solutions include the Multiport Delivery Device™ and QIKcap Disinfection Device™, which aim to improve compliance, prevent microbial ingress, and reduce healthcare-associated infections. The company is committed to quality and compliance, holding ISO 13485 certification and actively engaging in clinical research and industry collaborations to improve healthcare outcomes.
Industries
Nr. of Employees
small (1-50)
Hai Solutions
1234 Medical Drive, Healthcare City, HC 56789
Patents
Products
Multiport Delivery Device
A multiport intravenous delivery system engineered to improve compliance and reduce contamination risk during rapid sequencing of multiple medications by incorporating closed-loop, air-purge, and check-valve design elements.
QIKcap Disinfection Device
A device designed to rapidly disinfect the septum surface of intravenous connectors and access points to prevent microbial ingress during IV medication administration.
Multiport Delivery Device
A multiport intravenous delivery system engineered to improve compliance and reduce contamination risk during rapid sequencing of multiple medications by incorporating closed-loop, air-purge, and check-valve design elements.
QIKcap Disinfection Device
A device designed to rapidly disinfect the septum surface of intravenous connectors and access points to prevent microbial ingress during IV medication administration.
Services
End-to-end device development and production services, including prototype development and scaling to volume manufacturing aligned with customer and regulatory requirements.
Establishing supply and distribution agreements to commercialize intravenous device products in international markets.
End-to-end device development and production services, including prototype development and scaling to volume manufacturing aligned with customer and regulatory requirements.
Establishing supply and distribution agreements to commercialize intravenous device products in international markets.
Expertise Areas
- Vascular access device development
- Intravenous therapy infection prevention
- Medical device quality systems (ISO 13485)
- FDA regulatory submissions for medical devices
Key Technologies
- IV port septum disinfection devices
- Multiport IV delivery manifolds with closed-loop and air-purge features
- Check-valve integration for IV access to prevent retrograde flow
- Ultraviolet photochromic ink for disinfection/indicator applications
News & Updates
A conference focused on infection prevention and control, supporting members through education, research, and collaboration.
An event dedicated to setting the standard for infusion care, providing resources, education, and advocacy.
The submission marks a major achievement in delivering a next-generation IV port disinfection system.
The company announced a groundbreaking international supply and distribution agreement with a leading global disinfection industry company.
HAI Solutions was announced as the winner, sharing their innovative solutions on a national stage.
A strategic partnership to improve the quality and safety of IV vascular access using ultraviolet photochromic ink.
A conference focused on infection prevention and control, supporting members through education, research, and collaboration.
An event dedicated to setting the standard for infusion care, providing resources, education, and advocacy.
The submission marks a major achievement in delivering a next-generation IV port disinfection system.
The company announced a groundbreaking international supply and distribution agreement with a leading global disinfection industry company.
HAI Solutions was announced as the winner, sharing their innovative solutions on a national stage.
A strategic partnership to improve the quality and safety of IV vascular access using ultraviolet photochromic ink.